ACADEMIA

• Most Mild COVID-19 Patients Recovered on Avigan, but Careful Interpretations Needed for Single-Arm Study: Interim Report
  May 27, 2020

• Discontinued HIV Med Nelfinavir Hits Limelight as Potential COVID-19 Treatment
  May 26, 2020

• Avigan Interim Analysis Not Intended to Determine Efficacy, Research Sponsor Says on Reports
  May 21, 2020

• Infection Society's Updated COVID-19 Guide Includes Information on Veklury
  May 15, 2020

• Investigator Calls for Early Listing of Zolgensma in Japan
  May 12, 2020

• Univ. of Tokyo Starts Testing Avigan Plus Futhan for COVID-19
  May 11, 2020

• 5-Year Cancer Survival Rates Up 2 Points to 64.1%: NCC
  April 17, 2020

• Gunma Univ. Hospital Plans Clinical Research Covering Hydroxychloroquine
  April 13, 2020

• BCG’s Efficacy in COVID-19 Not Yet Confirmed: Japan Vaccine Society
  April 6, 2020

• Researchers Unlock SAL Inhibitory Mechanism of Obesity Med Orlistat; Potential Treatment for MRSA/Atopic Dermatitis
  March 30, 2020

• Otsuka, NCC Develop Comprehensive Genomic Profiling Assay for Blood Cancer
  March 27, 2020

• Japan Plans Alvesco Clinical Trial for Coronavirus
  March 24, 2020

• Japan to Join NIH-Sponsored COVID-19 Trial for Gilead’s Remdesivir
  March 24, 2020

• Pancreatitis Drug Nafamostat Potentially Effective for COVID-19: Researchers
  March 19, 2020

• COVID-19 Patients in Japan Improved on Plaquenil
  March 11, 2020

• Camostat Potential Treatment for COVID-19: German Study
  March 11, 2020

• Alvesco Inhibits RNA Replications: NIID
  March 9, 2020

• With Sudden Spotlight on Alvesco for COVID-19, Teijin Being Flooded with Inquiries
  March 6, 2020

• Asthma Drug Alvesco Possibly Effective for COVID-19
  March 4, 2020

• Kyoto Univ., NTT Launch New Company to Analyze, Provide RWD; Label Expansions Eyed for Cancer Drugs
  February 5, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• …
• Next ›
• 最終 »